TargetMol

Gersizangitide acetate

Product Code:
 
TAR-T40076L
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
 

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T40076L-1mg1mg£186.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T40076L-5mg5mg£306.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T40076L-10mg10mg£443.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T40076L-25mg25mg£831.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T40076L-50mg50mg£1,289.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T40076L-100mg100mg£1,988.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Gersizangitide acetate is an inhibitor of angiogenesis.
CAS:
0
Formula:
C113H171N29O30
Molecular Weight:
2415.74
Purity:
0.98
SMILES:
O=C([C@H](CCC1)N1C([C@H](C)NC([C@@]([C@H](O)C)([H])NC([C@H](CO)NC([C@@H](NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@@H](N)CC(C)C)=O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O)N[C@H](C(N[C@@H](C)C(N[C@H](C(N[C@]([C@@H](C)CC)([H])C(N[C@@H](CC(O)=O)C(N[C@]([C@@H](C)CC)([H])C(N[C@@H](CC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@]([C@@H](C)CC)([H])C(N[C@@H](CC(N)=O)C(N[C@H](C(N)=O)CC3=CC=CC=C3)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC4=CC=CC=C4)=O)=O)CC5=CC=CC=C5.CC(O)=O

References

WHO Drug Information, Vol. 35, No. 4, 202Geneva: World Health Organization; 2022.